baber/WOPTO huggingface dataset:
Patent JP-3812931-B2 (JP)
IPC: A23L15/00
Filed: 1999-12-01
Granted: 2006-08-23
Abstract: Disclosed are a novel desiccant containing a non-reducing anhydrous trehalose as an effective ingredient; a dehydration of hydrous matters, e.g. food products, pharmaceuticals and cosmetics, therewith; and dehydrated products obtained by the dehydration. Such hydrous matters are dehydrated without causing alteration or deterioration by incorporating anhydrous trehalose into the hydrous matters to convert the anhydrous trehalose into hydrous crystalline trehalose. The anhydrous trehalose are anhydrous crystalline trehalose and hydrous amorphous trehalose.
Patent JP-3081253-B2 (JP)
IPC: G01L9/00
Filed: 1990-12-27
Granted: 2000-08-28
Abstract: In an optically-excited micromachined silicon pressure sensor comprising a resonantly vibrating beam mounted on a diaphragm, vibration of the beam is sensed optically via the same optical fibre through which the optical excitation signal is applied to the sensor. The end of the fibre and the beam are arranged to define a cavity or gap whose width varies with vibration of the beam and which behaves as a Fabry-Perot cavity: thus light from the fibre is directed onto the beam and then reflected back to the fibre, the reflected light being modulated at the frequency of vibration of the beam. In order to overcome the difficulty of setting the gap or cavity width at an optimum value for light of a given wavelength, light of two different wavelengths is used to sense the vibrations, the wavelengths being selected such that the phase difference produced by the gap for one wavelength differs from that for the other wavelength by roughly 90 DEG .
Patent JP-3070950-B2 (JP)
IPC: C12R1/91
Filed: 1990-01-10
Granted: 2000-07-31
Abstract: The present invention provides a process and host cell for use in increasing the amount of a desired protein produced by a cell line. The process and the cell line use a first transcription unit containing a gene for a transactivator protein to control the transactivation of a second transcription unit such that the amount of desired protein expression can be increased without affecting adversely cell growth. Preferred transactivator proteins are derived from E1A.
Patent JP-2562815-B2 (JP)
IPC: C01B13/10
Filed: 1986-04-15
Granted: 1996-12-11
Abstract: Each ozonization loop (1) which includes a compressor (2), an ozonizer (3), and a heat exchanger (8) for cooling the oxygen-ozone mixture, is associated with three cylinders (4,5,6) filled with silica gel. Each cylinder operates in succession in a cocurrent adsorption, in countercurrent desorption by a substitution gas, and in scavenging by taking off a part of the flow circulating in the loop. The scavenging flow is recovered and combined with the substitution gas. The substitution gas may be in particular impure nitrogen supplied by an air distillation apparatus producing the necessary oxygen.
Patent JP-3386461-B2 (JP)
IPC: A61K31/505
Filed: 1992-06-30
Granted: 2003-03-17
Abstract: The present invention relates to a system comprising a modified bacterial gene for cytosine deaminase that has been engineered into a eukaryotic expression vector and the expression of the gene by mammalian cells. The present invention further relates to methods, gene therapies and vaccines that employ the negative selectable marker, cytosine deaminase, which has the ability to produce a toxic antimetabolic 5-fluorouracil from 5-fluorocytosine.
Patent JP-2557700-B2 (JP)
IPC: A61K31/085
Filed: 1988-04-08
Granted: 1996-11-27
Abstract: PCT No. PCT/FR88/00173 Sec. 371 Date Dec. 5, 1988 Sec. 102(e) Date Dec. 5, 1988 PCT Filed Apr. 8, 1988 PCT Pub. No. WO88/07856 PCT Pub. Date Oct. 20, 1988.The invention concerns chemical compounds consisting of the buty hydroxyanisoles and their salts for use in a method of therapeutic treatment of the human or animal body, in particular for use in a method of prophylactic or curative treatment of retroviral diseases, such as AIDS.
Patent JP-3647859-B2 (JP)
IPC: A61K9/22
Filed: 1993-07-22
Granted: 2005-05-18
Abstract: The present application is concerned with a solid slow release pharmaceutical dosage unit. More specifically, the invention is directed to a tablet form prepared by direct compression of cross-linked amylose (CLA) having a definite cross-linking degree, (alpha)-amylase and a pharmaceutical agent. The presence of the cross-linked amylose allows a sustained release of the drug, while the (alpha)-amylase permits the modulation of the release time. In other words, the release time of the drug is function of the amount of (alpha)-amylase in the tablet. The amount of (alpha)-amylase is defined in terms of Enzyme Units.
Patent JP-3471808-B2 (JP)
IPC: C08G69/10
Filed: 1995-07-28
Granted: 2003-12-02
Abstract: PCT No. PCT/EP95/03003 Sec. 371 Date Feb. 12, 1997 Sec. 102(e) Date Feb. 12, 1997 PCT Filed Jul. 28, 1995 PCT Pub. No. WO96/05241 PCT Pub. Date Feb. 22, 1996A process for preparing polyaspartic acid by polycondensation of fine-particle aspartic acid at temperatures above 150 DEG  C. in the presence of acidic catalysts, wherein first contact between the acidic catalysts and the fine-particle aspartic acid takes place in the reaction zone where the polycondensation takes place.
Patent JP-3004729-B2 (JP)
IPC: A61K47/18
Filed: 1995-09-07
Granted: 2000-01-31
Abstract: Immunoglobulin preparations, particularly liquid preparations of immunoglobulin G for intravenous infusion, are stabilized against dimer formation by the addition of one or more amphiphilic stabilizers. Preferred amphiphilic stabilizers are nicotinic acid derivatives, particularly nicotinamide, and naturally-occurring  alpha -amino acids having a lipophilic side chain, for example phenylalanine, proline, leucine and isoleucine.
Patent JP-2817978-B2 (JP)
IPC: B32B7/023
Filed: 1989-08-24
Granted: 1998-10-30
Abstract: A five-layer coating, commonly called a "stack", for glass windows in order to control the proportion of solar radiation permitted to pass through the window, the remainder being reflected by the coating, while maintaining a desired visible light characteristic transmission. Particularly, the technique is applied to vehicle glass windows, such as truck and automobile windshields, where the amount of solar radiation allowed to pass into the vehicle through the window is minimized within the constraints of maintaining visible light transmission above a certain legal level. The characteristics of the coating are also selected for visible light reflected from the window to the outside to be a substantially neutral color, highly desirable for the overall appearance of trucks and automobiles.
Patent JP-3433393-B2 (JP)
IPC: B29C49/56
Filed: 1992-09-02
Granted: 2003-08-04
Abstract: A plastic blow molding machine (40) having a wheel (44) rotatable on a base (42) about a horizontal axis (A) includes a plurality of mold stations (90) mounted on the wheel about the rotational axis and having a pair of mold supports (94) movable toward and away from each other in a parallel relationship to the rotational axis at closing and opening stations (114,116). Operating cams (120,124) of the closing and opening stations cooperate with operating cam followers (110) of the mold stations to provide closing and opening mold movement, and locking cam followers (122,126) of the closing and opening stations cooperate with locking cam followers (112) of the mold stations to lock and unlock a lock mechanism (102) that operates directly between the mold supports (94) of each mold station so that there is no loading of the frame (46) of the wheel during the machine operation. The operating cams (120,124) are preferably biased by associated operating gas springs (136,138), and the locking cams (122,126) are likewise preferably biased by locking gas springs (140,142). The wheel (44) includes a frame (46) having a pair of end frame portions (86) and a central frame portion (88). This central frame portion (88) has a pinion (166) mounted thereon and meshed with a pair of racks (170) respectively mounted on the pair of mold supports (94) to center the mold upon closing.
Patent JP-3443809-B2 (JP)
IPC: C07K19/00
Filed: 1993-03-08
Granted: 2003-09-08
Abstract: The present invention relates to new HIV peptides representing the gp41 and gp120 V3-loop immunodominant peptide regions of the new HIV isolate ANT70. The present invention also relates to methods for detection of antibodies specifically reacting with said peptides as well as diagnostic kits for performing said methods.
Patent JP-H0874-B2 (JP)
Inventor: COOK PHILIP DAN
IPC: C12N15/09
Filed: 1991-07-01
Abstract: PCT No. PCT/US91/04681 Sec. 371 Date Feb. 18, 1993 Sec. 102(e) Date Feb. 18, 1993 PCT Filed Jul. 1, 1991 PCT Pub. No. WO92/02258 PCT Pub. Date Feb. 20, 1992Oligonucleotide analogs are provided having improved nuclease resistance. Modifications of selected nucleotides through substitutions on the pyrimidine ring are disclosed. Certain preferred embodiments comprise the inclusion of said modified nucleotides at a plurality of sites, especially at the 3' end of a selected oligonucleotide analog.
Patent JP-3249526-B2 (JP)
IPC: G04F5/02
Filed: 1993-12-21
Granted: 2002-01-21
Abstract: PCT No. PCT/EP93/03644 Sec. 371 Date Aug. 9, 1995 Sec. 102(e) Date Aug. 9, 1995 PCT Filed Dec. 21, 1993 PCT Pub. No. WO94/18611 PCT Pub. Date Aug. 18, 1994A metronome mechanism comprises a bearing frame with a web and two limbs protruding from the web, a winding stem carrying a spring housing, a ratchet wheel stem carrying a ratchet wheel and bearing bushes arranged on the limbs of the bearing frame for receiving the ends of winding and ratchet wheel stems. The bearing bushes are formed on two separate side parts which are adapted to be pushed onto the limbs of the U-shaped bearing frame and firmly locked on the limbs.
Patent JP-2877517-B2 (JP)
IPC: G06K7/10
Filed: 1994-02-17
Granted: 1999-03-31
Abstract: An apparatus for illuminating and imaging a surface includes a two-dimensional array of LEDs for providing uniform illumination to the surface, the LEDs being mounted on a planar surface with a centrally defined aperture, and a CCD-based camera with appropriate lensing for obtaining an image of the illuminated surface and providing a signal representative of that obtained image to a processing unit, the CCD-based camera lensing being disposed through the centrally defined aperture in the planar surface of the LED array, and the LED array and CCD-camera lensing being disposed inside an opaque shroud.
Patent JP-3536129-B2 (JP)
IPC: C08K3/22
Filed: 1994-03-15
Granted: 2004-06-07
Abstract: Described is a new crystalline aluminum hydroxide which, because of its high-level purity and its outstanding electrical properties along with good viscosity characteristics, is especially well-suited for flame-proofing of thermosetting plastics that are used in electrical applications.
Patent JP-2960169-B2 (JP)
IPC: A61K9/16
Filed: 1994-04-21
Granted: 1999-10-06
Abstract: A solid preparation for a substantially immediate release of an active agent with low or very low solubility, which contains the active agent dissolved in a solubilizer, said dissolved active agent being contained in solid particles which are agglomerated into a system of agglomerated particles which is not a matrix or gelling forming agent.
Patent JP-4155413-B2 (JP)
IPC: H04L29/10
Filed: 1997-02-19
Granted: 2008-09-24
Abstract: An asynchronous data pipe (ADP) automatically generates transactions necessary to complete asynchronous data transfer operations for an application over a bus structure. The ADP includes a register file which is programmed and initiated by the application. The register file includes the bus speed, transaction label, transaction code, destination node identifier, destination offset address, length of each data packet, packet counter, packet counter bump field, control field and a status field. During a data transfer operation, the ADP generates the transactions necessary to complete the operation over the appropriate range of addresses, using the information in the register file as a template. The ADP increments the value in the destination offset address field for each transaction according to the length of each data packet, unless the incrementing feature has been disabled and the transactions are to take place at a fixed address. The packet counter represents the number of transactions remaining to be generated. The packet counter value is decremented after each packet of data is transferred. The application can increment the packet counter value by writing to the packet counter bump field. A multiplexer is included within a system having multiple ADPs for multiplexing the information from the ADPs onto the bus structure. A demultiplexer is included within a system having multiple ADPs for routing information from the bus structure to the appropriate ADP.
Patent ES-2244350-B2 (ES)
Title: Abrasivos revestidos mejorados.
Inventor: KNAPP CHRISTOPHER E
IPC: B24D3/28
Filed: 2003-03-21
Granted: 2007-02-01
Abstract: Un artículo abrasivo revestido, que comprende un material de soporte y granos de aglomerados abrasivos adheridos al soporte mediante un material aglutinante, caracterizado porque los granos de aglomerados usados comprenden una pluralidad de partículas abrasivas adheridas entre sí en una estructura tridimensional, , en la que cada partícula está unida a, al menos una partícula adyacente mediante un material aglutinante de partículas, el cual está presente en el aglomerado en forma de fase discontinua situada esencialmente de manera completa en forma de puestos de unión en el interior del grano de aglomerado, de manera que el aglomerado tiene un volumen de empaquetamiento flojo, que es al menos 2% más bajo que el de las partículas abrasivas en estado individual.
Patent ES-2465970-B2 (ES)
Title: Procedimiento y kit para la determinación de polifosfatos inorgánicos en plasma sanguíneo
Inventor: RUIZ RODRIGUEZ FÉLIX ALEJANDRO
IPC: G01N33/84
Filed: 2012-11-09
Granted: 2014-12-29
Abstract: Procedimiento y kit para la determinación de polifosfatos inorgánicos en plasma sanguíneo.#Constituye un objeto de la presente invención un procedimiento para la determinación de los niveles de polifosfatos inorgánicos en el plasma sanguíneo. Este procedimiento comprende el empleo de la fracción del plasma crioprecipitado que concentra la mayoría de los polifosfatos y reduce la contaminación del fosfato libre en la muestra.#Constituye otro objeto de la presente invención un kit para la determinación de los polifosfatos en plasma sanguíneo.
Patent ES-2564039-B2 (ES)
Title: Cerramiento de seguridad para animales y personas en vías de comunicación y otros espacios
Inventor: LOPEZ MARTIN ABEL
IPC: E04H17/00
Filed: 2015-12-04
Granted: 2016-07-01
Abstract: Cerramiento de seguridad para animales y personas en vías de comunicación y otros espacios, para impedir la intrusión de animales y personas, comprendiendo una valla principal (2) de postes (14, 14', 15) con malla alambrada (16), y sistema de evacuación activo que comprende un dispositivo (7) automático que, instalado en una o más zonas de evacuación (4) previstas en determinados puntos del cerramiento (1), detecta la presencia de los animales y acciona elementos que determinan vías de escape para los animales. Además de la valla principal (2) comprende, al menos, un tramo de valla secundaria (3) paralelo a la valla principal (2) por la parte interna de la misma, formando un embudo en la zona de evacuación (4), y dos puertas (6) motorizadas, situadas en la valla principal (2) en coincidencia con los extremos del tramo de valla secundaria (3), conectadas al dispositivo (7) de accionamiento automático.
Patent ES-2582011-B2 (ES)
Title: Máquina de fluido polivalente.
Inventor: ALVAREZ LOPEZ MANUEL
IPC: F01C20/22
Filed: 2016-05-11
Granted: 2017-07-07
Abstract: Máquina de fluido polivalente que cuenta con un rotor (2) acoplado radial y axialmente al interior de una carcasa (1), donde la geometría del rotor (2) en sintonía con la de la carcasa (1) puede diseñarse con multitud de siluetas configuradas por pares de arcos, no condicionados por formas regulares, cilíndricas o simetrías. Resultan tantos pares de vías entrada-salida (3', 3''  4', 4'') como pares de arcos conformen al rotor (2). El rotor (2) obedece a un movimiento traslacional asistido por medios de guiado (5) alojados en cualquier parte del mismo (2). Con sólo interactuar con la alimentación de las vías de entrada (3', 3'') o de salida (4', 4'') puede operar indistintamente como máquina generadora, motora, reversible o transmisora, incluso como máquina motora y generadora al unísono careciendo de ejes que salgan al exterior de la carcasa (1).
Patent AU-2001250683-B2 (AU)
Title: Peptide-based compounds
Inventor: CUTHBERTSON ALAN
IPC: A61P29/00
Filed: 2001-04-06
Granted: 2006-06-29
Abstract: The invention relates to new peptide-based compounds for use as diagnostic imaging agents or as therapeutic agents wherein the agents comprise a targeting vector which binds to receptors associated with integrin receptors.
Patent AU-2002211136-B2 (AU)
Title: Device for operating a door leaf or the like and door structure provided with such a device
Inventor: BACKMAN ERIC
IPC: E05F3/22
Filed: 2001-10-19
Granted: 2007-05-31
Abstract: A device for opening and closing a pivotally mounted door leaf including an actuator, which is displaceably and/or rotatingly arranged in a housing and connected to the door leaf and which, during displacement/rotation, actuates the door leaf, and a drive motor which is connected to the actuator for providing displacement/rotation thereof.
Patent AU-2002224816-B2 (AU)
Title: Brazing product having a low melting point
Inventor: WIJENBERG JACQUES HUBERT OLGA
IPC: B32B15/01
Filed: 2001-10-30
Granted: 2005-06-16
Abstract: The invention relates to an aluminium brazing product, such as a brazing sheet product, comprising an aluminium alloy base substrate (1) of an aluminium alloy comprising silicon in an amount in the range of 2 to 18% by weight, and on at least one outlet surface a layer (2) comprising nickel, wherein a separately deposited layer (3) is applied on one side of said layer (2) comprising nickel, and wherein said layer (3) comprising a metal such that taken together said aluminium base substrate (1) and all layers exterior thereto form a metal filler having a liquidus temperature in the range of 490 to 570 DEG C. The invention also relates to a method of manufacturing such an aluminium brazing product and to a brazed assembly comprising at least one component made of the aluminium brazing product.
Patent AU-2002243442-B2 (AU)
Title: Indolocarbazole anticancer agents and methods of using them
Inventor: ZHOU YASHEEN
IPC: C07H19/04
Filed: 2001-10-29
Granted: 2004-11-04
Abstract: The present invention relates to anti-tumor compounds, compositions and methods. In particular, the invention relates to indolocarbazole analogues of the following general formulas that inhibit topoisomerase I activity
Patent AU-2002244711-B2 (AU)
Title: Method for purifying 20(S)-camptothecin
Inventor: SOBOTTA RAINER
IPC: C07D491/04
Filed: 2002-02-09
Granted: 2007-05-31
Abstract: The invention relates to a method for purifying 20(S) camptothecin by transforming the lactone ring of the 20(S) camptothecin into a carboxylate salt with the help of an aqueous base, hydrogenating the mixture that is obtained in the presence of a transition metal catalyst, acidifying the aqueous phase to form camptothecin crystals, adding a polar aprotic solvent, optionally heating and cooling the mixture and separating the camptothecin crystals.
Patent AU-2002255321-B2 (AU)
Title: Tablets quickly disintegrating in the oral cavity and process for producing the same
Inventor: MASUDA YOSHINORI
IPC: A61K47/26
Filed: 2002-05-08
Granted: 2007-05-17
Abstract: The present invention relates to a quick-disintegrating tablet in the buccal cavity comprising a drug, a diluent, and a saccharide with a relatively lower melting point than the drug and the diluent, which is obtained by uniformly mixing the saccharide with a low melting point in the tablet so that a bridge will be formed between said drug and/or said diluent particles by the product of melting and then solidification of this saccharide with a low melting point. Moreover, the present invention relates to a method of manufacturing a quick-disintegrating tablet in the buccal cavity comprising a drug, a diluent and a saccharide with a relatively lower melting point than the drug and the diluent, which comprises (a) the process whereby tablet starting materials including a drug, a diluent, and a saccharide with a relatively lower melting point than the drug and the diluent are molded under the low pressure necessary for retaining the shape of a tablet, (b) the process whereby the molded product obtained in process (a) is heated to at least the temperature at which this saccharide with a low melting point will melt, and (c) the process whereby the molded product obtained in process (b) is cooled to at least the temperature at which the molten saccharide with a low melting point solidifies. The present invention presents a quick-disintegrating tablet in the buccal cavity that can be used for practical purposes in that it has almost the same properties as conventional oral pharmaceutical tablets, that is, it has sufficient tablet strength that it can be used with automatic unit dosing machines, and it is produced by conventional tableting machines, and a manufacturing method thereof. Moreover, the present invention presents a quick-disintegrating tablet in the buccal cavity which, in comparison to conventional quick-disintegrating tablets in the buccal cavity, has increased tablet strength and an improved friability without prolonging the disintegration time in the buccal cavity, and a manufacturing method thereof.
Patent AU-2002257562-B2 (AU)
Title: Deuterated 3-Piperidinopropiophenone and medicaments containing said compounds
Inventor: ALKEN RUDOLF-GISBERT
IPC: A61K31/4453
Filed: 2002-04-29
Granted: 2007-01-11
Abstract: The invention discloses deuterated 3-piperidinopropiophenones as well as their physiologically tolerated salts. Furthermore, the invention concerns the use of deuterated 3-piperidinopropiophenones for the treatment of muscular illnesses as well as for the preparation of pharmaceutical drugs for the treatment of muscular illnesses. In addition, the invention discloses pharmaceutical formulations containing deuterated 3-piperidinopropiophenones as well as their physiologically tolerated salts for the treatment of muscular illnesses in addition to containing pharmaceutically tolerated adjuvants and/or additives.
Patent AU-2003265118-B2 (AU)
Title: Optical disc, method and apparatus for managing a defective area on an optical disc
Inventor: PARK YONG CHEOL
IPC: G11B7/007
Filed: 2003-10-01
Granted: 2009-08-27
Abstract: The present invention relates to a write-once recording medium (21) having a lead-in area, a data area having a user data area and one or more spare areas, and an outer zone, the recording medium (21) including a plurality of defect management areas located in the lead-in area and the outer zone for storing defect management information when the recording medium (21) is to be finalized, the one or more spare areas being used for a replacement writing, the recording medium (21) comprising: a temporary defect list area for storing defect list information for a defective area detected in the data area; a navigation pointer pointing to the defect list information written in the temporary defect list area; and location information indicating a next available location of each spare area for a successive replacement writing.  Furthermore, the present invention relates to an apparatus for managing storage of defect management information onto a write-once recording medium (21) and an apparatus for managing reproduction of defect management information from a write-once recording medium (21).